Ovarian cancer (including fallopian tube and peritoneal) can be difficult to detect in early stages, and symptoms tend to be vague. That's why you need a team of true experts.
At Holden Comprehensive Cancer Center at the University of Iowa, we are highly coordinated at every step, with the latest research to deliver the best care for you. As part of a nationally recognized cancer center, our highly experienced physicians and staff are dedicated to taking care of you, not just your cancer. Our clinicians are also top researchers, finding new and innovative treatments and therapies. Enroll in a clinical trial to get ahead of the game.
A recent study published in the journal Cancer showed that patients treated at NCI-designated cancer centers have better survival outcomes than patients treated at non–NCI-designated cancer centers. Holden Comprehensive Cancer Center is the only institution in Iowa to hold the prestigious designation of being a Comprehensive Cancer Center by the National Cancer Institute (NCI), meaning we are rated in the top 4 percent of the approximately 1,500 cancer centers in the United States.
To be considered a "comprehensive" center means our teams have expertise in clinical, laboratory, and population-based research. Our doctors and staff are on top of the newest developments in cancer research, treatment, and diagnosis.
Clinical trials are where research meets patient care. Clinical trials are research studies that test out the latest treatments and drugs that are not yet available to the wider public. These new treatments have the potential to improve your quality of life or increase your chances of survival.
Currently enrolling: A few different studies are currently enrolling that are testing the effectiveness of different drugs; eligibility will depend on disease type, progression, recurrence, and other factors. Search our database, and type "ovary" next to "disease site." In addition, a study is testing a way to help physicians identify women 70 years and older who would do well with surgery. It involves a questionnaire and blood work.
See a full list and learn more about clinical trials at Holden Comprehensive Cancer Center.
For providers: Proceedings in Obstetrics and Gynecology is an open-access peer-reviewed journal that the Department of Obstetrics and Gynecology at the University of Iowa launched in 2010.
Ovarian cancer is cancer that starts in the ovaries. The ovaries are the female reproductive organs that produce eggs. There are three main types of ovarian tumors:
Treatment plans for ovarian, fallopian tube, or peritoneal cancer may include:
We bring experts from different fields of medicine to work together as a team called a multidisciplinary oncology group. Because many patients require more than one form of treatment, our team meets regularly to discuss the best course of treatment and works together to design the best personalized plan for every patient. The team includes radiologists, gynecologic oncologists, social workers, pathologists, pharmacists, nurses, and laboratory-based scientists.
Our team of specialists focuses not just on gynecologic cancer, but on your gynecologic cancer. That means our team of experts will design a treatment plan that is tailored to your individual needs.